From housekeeper to microsurgeon: The diagnostic and therapeutic potential of ribonucleases

Nature Biotechnology

Volumn 15, Issue 6, 1997, Pages 529-536

  Schein, Catherine H ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Ampligen; Angiogenin; Antiviral drugs; Cancer therapy; Immunotoxins; Interferons; Onconase; Oragen; Pancreatic ribonuclease; Ribonucleases; RNase E; RNase H; RNase L; RNase P

Indexed keywords

ALLERGEN; ANGIOGENIN; NEUROTOXIN; RIBONUCLEASE;

ALLERGY; ANTIVIRAL ACTIVITY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DIAGNOSTIC VALUE; DRUG RESEARCH; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

ALLERGENS; AMINO ACID SEQUENCE; ANIMALS; DRUG DESIGN; HOMEOSTASIS; HUMANS; MOLECULAR SEQUENCE DATA; NEUROTOXINS; OLIGONUCLEOTIDES, ANTISENSE; PANCREAS; PROTEINS; RIBONUCLEASE H, CALF THYMUS; RIBONUCLEASE, PANCREATIC; RIBONUCLEASES; RNA PROCESSING, POST-TRANSCRIPTIONAL; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0030940829     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0697-529     Document Type: Article

References (115)

1. Confalone, E., Beintema, J.J., Sasso, M.P., Carsana, A., Palmieri, M., Vento, M.T., and Furia, A. 1995. Molecular evolution of genes encoding ribonucleases in ruminant species. J. Mol. Evol. 41:850-858.
2. Tharun, S. and Sirdeshmukh, R. 1995. Specific endonucleolytic cleavages of mouse albumin mRNA and their modulation during liver development. Nuc. Acids Res. 23:641-6.
3. Rosenberg, H.F. and Dyer, K.D. 1995. Human ribonuclease 4 (RNase 4):coding sequence, chromosomal localization and identification of two distinct transcripts in human somatic tissues. Nuc. Acids Res. 23:4290-4295.
4. Reddi, K.K. 1975. Nature and possible origin of human serum ribonuclease. Biochem. & Biophys. Res. Comm. 67:110-118.
5. Bartholeyns, J.A.U., Peeters-Joris, C.A.U., and Baudhuin, P. 1975. Hepatic nucleases. Extrahepatic origin and association of neutral liver ribonuclease with lysosomes. Eur. J. Biochem. 60:385-393.
6. Liu, D.K. and Owens, G.F. 1983. Mammary origin of rat milk ribonuclease. Inter. J. Biochem. 15:1273-1277.
7. Weickmann, J.L. and Glitz, D.G. 1982. Human ribonucleases. Quantitation of pancreatic-like enzymes in serum, urine, and organ preparations. J. Biol. Chem. 257:8705-8710.
8. Menella, M.R. and Jones, M.R. 1977. The activity of some nucleolytic enzymes in semen and in the secretion of the male reproductive tract. Andrologia 9:15-22.
9. Tiffany, H.L., Handen, J.S., and Rosenberg, H.F. 1996. Enhanced expression of the eosinophil-derived neurotoxin ribonuclease (RNS2) gene requires interaction between the promoter and the intron. J. Biol. Chem. 271:12387-12393.
10. Chow, J. and Dennis, P.P. 1994. Coupling between mRNA synthesis and mRNA stability in Escherichia coli. Mol. Microbiol. 11:919-931.
11. Jain, C. and Belasco, J.G. 1995. RNase E autoregulates its synthesis by controlling the degradation rate of its own mRNA in Escherichia coil: unusual sensitivity of the rne transcript to RNase E activity. Genes & Devel. 9:84-96.
12. Presutti, C., Villa, T.A.U., Hall, D., Pertica, C., and Bozzoni, I. 1995. Identification of the cis-elements mediating the autogenous control of ribosomal protein L2 mRNA stability in yeast. EMBO J. 14:4022-4030.
13. Dementiev, A.A., Mirgorodskaya, O.A., Moiseyev, G.P., Yakovlev, G.I., Shlyapnikov, S.V., and Kirpichnikov, M.P. 1996. A novel guanyl-preferable ribonuclease of Bacillus polymyxa-isolation and characterization of the enzyme. Biochem. & Mol. Biol. Intl. 39:159-170.
14. Kobe, B. and Deisenhofer, J. 1995. A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature 374:183-186.
15. Hofsteenge, J. 1994. ‘Holy’ proteins. I: Ribonuclease inhibitor. Curr. Opin. Struct. Biol. 4:807-809.
16. Schneider, R. and Schweiger, M. 1992. The yeast RNA1 protein, necessary for RNA processing, is homoiogous to the human ribonuclease/angiogenin inhibitor (RAI). Mol. Gen. Genet. 233:315-318.
17. Nadano, D., Yasuda, T., Takeshita, H., Uchide, K., and Kishi, K. 1994. Purification and characterization of human brain ribonuclease inhibitor. Archives Biochem. Biophys. 312:421-428.
18. Stoeckle, M.Y. and Guan, L. 1993. High-resolution analysis of groα mRNA poly(A) shortening: regulation by interleukin-1ß. Nuc. Acids Res. 21:1613-1617.
19. Lengyel, P. 1993. Tumor-suppressor genes: news about the interferon connection. Proc. Natl. Acad. Sci. 90:5893-5895.
20. Cole, J.L., Carroll, S.S., and Kuo, L.C. 1996. Stoichiometry of 2′5′ oligoadenylate-induced dimerization of ribonuclease L—a sedimentation equilibrium study. J. Blol. Chem. 271:3979-3981.
21. Bisbal, C., Martinand, C., Silhol, M., Lebleu, B., and Salehzada, T. 1995.Cloning and characterization of a RNase L inhibitor. A new component of the interferon-regulated 2-5A pathway. J. Biol. Chem. 270:13308-13317.
22. Schein, C.H., Haugg, M., and Benner, S.A. 1990. Interferon-γ activates the cleavage of double stranded RNA by bovine seminal ribonuclease. FEBS Letters 270:229-232.
23. Schein, C.H. and Haugg, M. 1995. The role of the C-terminus of human inter-feron-γ in RNA binding and activation of the cleavage of ds-RNA by bovine seminal ribonuclease. Biochem. J. 307:123-127.
24. Gessani, S., DiMarzio, P., Rizza, P., Belardelli, F., and Baglioni, C. 1991 Post-transcriptional regulation of interferon mRNA levels in peritoneal macrophages. J. Virol. 65:989-991.
25. Lappin, D.F., Guc, D., Hill, A., McShane, T., and Whaley, K. 1992. Effect of interferon-γ on complement gene expression in different cell types. Biochem. J. 281:437-442.
26. Radzich, D. and Varesio, L. 1991. c-fos mRNA expression in macrophages is downregulated by interferon-γ at the post-transcriptional level. Mol. Cell. Biol. 11:2718-2722.
27. Kasama, T., Strieter, R.M., Lukacs, N.W., Lincoln, P.M., Burdick, M.D., and Kunkel, S.L. 1995. Interferon gamma modulates the expression of neutrophil-derived chemokines. J. Invest. Med. 43:58-67.
28. Besancon, F., Przewlocki, G., Baró, I., Hongre, A., Escande, D., and Edelman, A. 1994. Interferon-γ downregulates CFTR expression in epithelial cells. Am. J. Physiol. (Cell Physiol) 36:C1398-C1404.
29. Schein, C.H. 1997. An enzymatic cell free assay to detect direct inhibitors of interferon—γ. In Vitro Toxicol. In press.
30. Albanese, A.A., Lorenze, E.J., Orto, L.A., Wein, E.A., Zavattoro, D.M., and Carlo, R.D. 1972. Nutritional and metabolic effects of some newer steroids. VI. Serum Ribonuclease. N.Y. State J. Med. 19:1595-1600.
31. Menella, M.R. and Jones, M.R. 1977. The activity of some nucleolytic enzymes in semen and in the secretion of the male reproductive tract. Andrologia 9:15-22.
32. Zelenko, O., Neumann, U., Brill, W., Pieles, U., Moser, H.E., and Hofsteenge, J. 1994. A novel fluorogenic substrate for ribonucleases. Synthesis and enzymatic characterization. Nucl. Acids Res. 22:2731-2739.
33. Newton, D.L., Walbridge, S., Mikulski, S.M., Ardelt, W., Shogen, K., Ackerman, et al. 1994, Toxicity of an antitumor ribonuclease to Purkinje neurons. J. Neuroscience 14:538-544.
34. Bufe, A., Spangfort, M.D., Kahlert, H., Schlaak, M., and Becker, W.M. 1996. The major birch pollen allergen, BEt V1, shows ribonuclease activity. Planta 199:413-415.
35. Sassa, H., Nishio, T., Kowyama, Y., Hirano, H., Koba, T., and Ikehashi, H. 1996. Self incompatibility (S) alleles of the Rosaceae encode members of a distinct class of the T2/S ribonuclease superfamily. Mol. & Gen. Genet. 250:547-557.
36. Ye, Z.H. and Droste, D.L. 1996. Isolation and characterization of cDNAs encoding Xylogenesis-associated and wound-inducing ribonucleases in Zinnia elegans. Plant Mol. Biol. 30:697-709.
37. Walter, M.H., Liu, J.W., Wunn, J., and Hess, D. 1996. Bean ribonuclease-like pathogenesis related protein genes (YPR10) display complex patterns of developmental, dark induced and exogenous-stimulus-dependent expression. Eur. J. Biochem. 239:281-293.
38. Francesconi, M., Meryn, S., Rogan, A.M., Szalay, S., Graninger, W., and Schmidbauer, C.P. 1984. Poly (C) avid ribonuclease estimation in patients with solid tumors. A critical evaluation. Cancer 53:1927-1930.
39. Hatzelmann, A., Tenor, H., and Schudt, C. 1995. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions. British J. Pharmacol. 114:821-831.
40. Okada, N. and Koizumi, S. 1995. A neuroprotective compound, aurin tricarboxylic acid, stimulates the tyrosine phosphorylation cascade in PC12 cells. J. Biol. Chem. 270:16464-16469.
41. Murphy, N.R., Leinbach, S.S., and Hellwig, R.J. 1995. A potent, cost-effective RNase inhibitor. Bio Techniques 18:1068-1073.
42. Ogawa, T., Hori, T., and Ishida, I. 1996. Virus-induced cell death in plants expressing the mammalian 2′,5′ oligoadenylate system. Nature Biotechnology 14:1566-1569.
43. Sobol, R.W., Henderson, E.E., Kon, N., Shao, J., Hitzges, P., Mordechai, E., Reichenbach, N.L., Charubala, R., Schirmeister, H., Pfleiderer, W., and Suhadolnik, R.J. 1995. Inhibition of HIV-1 replication and activation of RNase L by phosphorothioate/phosphodiester 2′,5′-oligoadenylate derivatives. J. Biol. Chem. 270:5963-5978.
44. Fingerote, R.J., Cruz, B.M., Gorczynski, R.M., Fung, L.S., Hubbell, H.R., Suhadolnik, R.J., and Levy, G.A. 1995. A 2′,5′-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice. J. Gen. Virol. 76:373-380.
45. Ushijima, H., Rytik, P.G., Schacke, H., Scheffer, U., Muller, W.E., and Schroder, H.C. 1993. Mode of action of the anti-AIDS compound poly(l).poly(C12U) (Ampligen): activator of 2′,5′-oligoadenylate synthetase and double-stranded RNA-dependent kinase. J. Interferon Res. 13:161-171.
46. Cheney, P., Salvato, P., Thompson, C., Loveless, M., Muller, W.E., et al. 1994. Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(l)-poly(C12U) in chronic fatigue syndrome. In Vivo 8:599-604.
47. Liao, Y.D., Huang, H.C., Chan, H.J., and Kuo, S.J. 1996. Large-scale preparation of a ribonuclease from Rana catesbeiana (bullfrog) oocytes and characterization of its specific cytotoxic activity against tumor cells. Prot. Express. Purif. 7:194-202.
48. Rybak, S.M., Pearson, J.W., Fogler, W.E., Volker, K., Spence, S.E., Newton, D.L., Mikulski, S.M., Ardelt, W., Riggs, C.W., Kung, H.F., and Longo, D.L. 1996. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease. J. Natl. Cancer Inst. 88:747-753.
49. Newton, D.L., Pearson, J.W., Xue, Y., Smith, M.R., Fogler, W.E., Mikulski, S.M., Alvord, W.G., Kung, H.F., Longo, D.L., and Rybak, S.M. 1996. Anti-tumor ribonuclease, combined with or conjugated to monclonal antibody MRK16, overcomes multidrug resistance to vincristine in vitro and in vivo. Int. J. Oncol. 8:1095-1104.
50. Haugg, M. and Schein, CH. 1992. The DNA sequences of the human and hamster secretory ribonucleases determined with the polymerase chain reaction (PCR). Nuc. Acids Res. 20:612.
51. Rosenberg, H.F. and Dyer, K.D. 1995. Eosinophil cationic protein and Eosinophil neurotoxin. Evolution of novel function in a primate ribonuclease gene family. J. Biol. Chem. 270:21539-21544.
52. Dong, B., Xu, L., Zhou, A., Hassel, B.A., Lee, X., Torrence, P.F., and Silverman, R.H. 1994. Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNA. J. Biol. Chem. 269:14153-14158.
53. Wennborg, A., Sohlberg, B., Angerer, D., Klein, G., and von Gabain, A. 1995. A human RNase E-like activity that cleaves RNA sequences involved in mRNA stability control. Proc. Natl. Acad. Sci. 92:7322-7326.
54. Boeck, R., Tarun, S., Rieger, M., Deardorff, J.A., Muller-Auer, S., and Sachs, A.B. 1996. The yeast PAN2 protein is required for poly (A)-binding-protein stimulated poly (A)-nuclease activity. J. Biol. Chem. 271:432-438.
55. Trabesingerruef, N., Jermann, T., Zankel, T., Durrant, B., Frank, G., and Benner, S.A. 1996. Pseudogenes in ribonuclease evolution—a source of new blomacromolecular function. FEBS Letters 382:319-322.
56. 2, binding site. Point mutations at Lys-7 and Arg-10 alter the catalytic properties of the enzyme. J. Biol. Chem. 269:2529-2534.
57. Moussaoui, M., Guasch, A., Boix, E., Cuchillo, C.M., and Nogués, M.V. 1996. The role of non-catalytic binding subsites in the endonuclease activity of bovine pancreatic ribonuclease A. J. Biol. Chem. 271:4687-4692.
58. Mosimann, S.C, Ardelt, W., and James, M.N.G. 1994. 1.7 Å X-ray crystalographic structure of P-30 protein, an amphibian ribonuclease with antitumor activity. J. Mol. Biol. 236:1141-1153.
59. Mosimann, S.C., Newton, D.L., Youle, R.J., and James, M.N.G. 1996. X-ray crystallographic structure of recombinant eosinophil-derived neurotoxin at 1.83 Å resolution. J. Mol. Biol. 260:540-552.
60. Lequin, O., Albaret, C., Bontems, F., Spik, G., and Lallemand, J.Y. 1996. Solution structure of bovine angiogenin by H-1 nuclear magnetic resonance spectroscopy. Biochem. 35:8870-8880.
61. Kim, J.S., Soucek, J., Matousek, J., and Raines, R.T. 1995. Mechanism of ribonuclease cytotoxicity. J. Biol. Chem. 270:31097-31102.
62. Capasso, S., Didonato, A., Esposito, L., Sica, R, Sorrentino, G., Vitagliano, L., et al. 1996. Deamidation in proteins—the crystal structure of bovine pancreatic ribonuclease with an isoaspartyl residue at position 67. J. Mol. Biol. 257:492-496.
63. Boix, E., Wu, Y.N., Vasandani, V.M., Saxena, S.K., Ardelt, W., Ladner, J., and Youle, R.J. 1996. Role of the N terminus in RNase A Homologues—Differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity. J. Mol. Biol. 257:992-1007.
64. Carroll, S.S., Chen, E., Viscount, T., Geib, J., Sardana, M.K., Gehman, J., and Kuo, L.C 1996. Cleavage of oligoribonucleotides by the 2′5′-oligoadenylate-dependent ribonuclease L. J. Biol. Chem. 271:4988-4992.
65. Okorokov, A.L., Panov, K.I., Kolbanovskaya, E.Y., Karpeisky, M.Y., Poiyakov, K.M., Wilkinson, A.J., and Dodson, G.G. 1996. Site-directed mutagenesis of the base recognition loop of ribonuclease from Bacillus intermedius (binase). FEBS Letters 384:143-146.
66. Parente, D., Raucci, G., Celano, B., Pacilli, A., Zanoni, L., Canevari, S., et al. 1996. Clavin A Type-1 ribosome-inactivating protein from Aspergillus clavatus IFO 8605-cDNA isolation, heterologous expression, biochemical and biological characterization for the recombinant protein. Eur. J. Biochem. 239:272-280.
67. Szewczak, A.A., Moore, P.B., Chang, Y.L., and Wool, I.G. 1993. The conformation of the sarcin/ricin loop from 28S ribosomal RNA. Proc. Natl. Acad. Sci. 90:9581-9585.
68. Wool, I.G. 1984. The mechanism of action of the cytotoxic nuclease α-sarcin and its use to analyse ribosome structure. TIBS 9:14-17.
69. Cheung, J.I., Wang, Y.R., and Lin, A. 1996. Substrate specificity of monomeric and dimeric alpha-sarcin. FEBS Letters 386:60-64.
70. Morris, K.N. and Wool, I.G. 1992. Determination by systematic deletion of the amino acids essential for catalysis by ricin A chain. Proc. Natl. Acad. Sci. 89:4869-4873.
71. Py, B., Causton, H., Mudd, E.A., Higgins, C.F. 1994. A protein complex mediating mRNA degradation in Escherichia coli. Mol. Microbiol. 14:717-729.
72. Carpousis, A.J., Van Houwe, G., Ehretsmann, C., and Krisch, H.M. 1994. Copurification of E. coli RNAase E and PNPase: evidence for a specific association between two enzymes important in RNA processing and degradation. Cell 76:889-900.
73. Cazenave, C., Frank, R, Toulme, J.J., and Busen, W. 1994. Characterization and subcellular localization of ribonuclease H activities from Xenopus laevis oocytes. J. Biol. Chem. 269:25185-15192.
74. Hue, K.K., Cohen, S.D., and Bechhofer, D.H. 1995. A polypurine sequence that acts as a 5′ mRNA stabilizer in Bacillus subtilis. J. Bacteriol. 177:3465-3471.
75. Kowalak, J.A., Dalluge, J.J., McCloskey, J.A., and Stetter, K.O.1994. The role of posttranscriptional modification in stabilization of transfer RNA from hyper-thermophiles. Biochem. 33:7869-7876.
76. Kowalak, J.A., Pomerantz, S.C., Crain, P.F., and McCloskey, J.A. 1993 A novel method for the determination of post-transcriptional modification in RNA by mass spectrometry. Nuc. Acids Res. 21:4577-4585.
77. Giles, R.V., Spiller, D.G., and Tidd, D.M. 1995. Detection of ribonuclease H-generated mRNA fragments in human leukemia cells following reversible membrane permeabilization in the presence of antisense oligodeoxynucleotides. Antisense Res. & Devel. 5:23-31.
78. Augustyns, K., Godard, G., Hendrix, C., Van Aerschot, A., Rozenski, J., Saison-Behmoaras, T., and Herdewijn, P. 1993. Hybridization specificity, enzymatic activity and biological(Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-beta-D-erythro-hexopyranosyl nucleosides. Nuc. Acids Res. 21:4670-4676.
79. Giles, R.V., Ruddell, C.J., Spiller, D.G., Green, J.A., and Tidd, D.M. 1995. Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cells. Nuc. Acids Res. 23:954-961.
80. Blain, S.W., Hendrickson, W.A., and Goff, S.P. 1995. Reversion of a Moloney murine leukemia virus RNase H mutant at a second site restores enzyme function and infectivity. J. Virol. 69:5113-5116.
81. Blain, S.W. and Goff, S.P. 1993. Nuclease activities of Moloney murine leukemia virus reverse transcriptase. Mutants with altered substrate specificities. J. Biol. Chem. 268:23585-23592. The authors used a gel based solid state assay to eliminate the possibility that the proteins were contaminated with E. coli RNase III.
82. Götte, M., Fackier, S., Hermann, T., Perola, E., Cellai, L., Gross, H.J., et al. 1995. HIV-1 reverse transcriptase-associated RNase H cleaves RNA/RNA in arrested complaxes: implications for the mechanism by which RNase H discriminates between RNA/RNA and RNA/DNA. EMBO J. 14:833-841.
83. Palaniappan, C., Fay, P.J., and Bambara, R.A. 1995. Nevirapine alters the cleavage specificity of ribonuclease H of human immunodeficiency virus 1 reverse transcriptase. J. Biol. Chem. 270:4861-4869.
84. Mcdowall, K.J. and Cohen, S.N. The N-terminal domain of the RNE gene product has RNase E activity and is non-overlapping with the arginine rich RNA-binding site. J. Mol. Biol. 255:349-355.
85. Bork, P. and Sander, C. 1993. A hybrid protein kinase-RNase in an interferon-induced pathway? FEBS Letters 334:149-152.
86. Jinno, H., Ueda, M., Ozawa, S., Kikuchi, K., Ikeda, T., Enomoto, K., and Kitajima, M. 1996. Epidermal growth factor receptor-dependent cytotoxic effect by an EGF-ribonuclease conjugate on human cancer cell lines—a trial for less immunogenic chimeric toxin. Cancer Chemo. & Pharmacol. 38:303-308.
87. Newton, D.L., Xue, Y., Olson, K.A., Fett, J.W., and Rybak, S.M. 1996. Angiogenin single-chain immunofusions—influence of peptide linkers and spacers between fusion protein domains. Biochem. 35:545-543.
88. Melkohovets, Y.F. and Joshi, S. 1996. Fusion with an RNA binding domain to confer target RNA specificity to an RNase—design and engineering of TAT-RNase H that specifically recognizes and cleaves HIV-1 RNA in vitro. Nucl. Acids Res. 24:1908-1912.
89. Hertler, A.A. and Frankel, A.E. 1989. Immunotoxins: a clinical review of their use in the treatment of malignancies. J. Clin. Oncol. 7:1932-1942.
90. Houston Biotechnology 4197X-RA
91. Turnay, J., Olmo, N., Jimenez, A., Lizarbe, M.A., and Gavilanes, J.G. 1993. Kinetic study of the cytotoxic effect of alpha-sarcin, a ribosome inactivating protein from Aspergillus giganteus, on tumour cell lines: protein biosynthesis inhibition and cell binding. Mol. Cell. Biochem. 122:39-47.
92. Kijima, H., Ishida, H., Ohkawa, T., Kashani-Sabet, M., and Scanlon, K.J. 1995. Therapeutic applications of ribozymes. Pharm. and Therapeutics 68:247-267.
93. Usman, N., Beigelman, L., and McSwiggen, J.A. 1996. Hammerhead ribozyme engineering. Curr. Opin. Struct. Biol. 6:527-533.
94. Nakai, C., Konishi, A., Komatsu, Y., Inoue, H., Ohtsuka, E., and Kanaya, S. 1994. Sequence-specific cleavage of RNA by a hybrid ribonuclease H. FEBS Letters 339:67-72.
95. Brown, J.W., Nolan, J.M., Haas, E.S., Rubio, M.A.T., Major, F., and Pace, N.R. 1996. Comparative sequence analysis of ribonuclease P RNA using gene sequences from natural microbial populations reveals tertiary structural elements. Proc. Natl. Acad. Sci. 93:3001-3006.
96. Brown, J.W. 1996. The ribonuclease P database. Nuc. Acids Res. 24:236-237.
97. Liu, F. and Altman, S. 1995. Inhibition of viral gene expression by the cataltytic RNA subunit of RNase P from Escherichia coli. Genes & Devel. 9:471-480.
98. Kufel, J. and Kirsebom, L.A. 1994. Cleavage site selection by M1 RNA, the catalytic subunit of Escherichia coli RNase P, is influenced by pH. J. Mol. Biol. 244:511-121.
99. Truffert, J.C., Asseline, U., Brack, A., and Thuong, N.T. 1996. Synthesis. purification, and characterization of two peptide-oligonucleotide conjugates as potential artificial nucleases. Tetrahedron 52:3005-3016.
100. Bufe, A., Schramm, G., Petersen, A., Schlaak, M., and Becker, W.M. 1997. The function of allergens may determine allergenicity. in New Horizons in Allergy Immunotherapy. Sehon, A., Kraft, D., and Hayglass, K.T. (eds). Plenum Publishing, New York, London, Washington DC, Moscow. In press.
101. Szewczak, A.A., Moore, P.B., Chang, Y.L., and Wool, I.G. 1993. The conformation of the sarcin/ricin loop from 28S ribosomal RNA. Proc. Natl Acad. Sci. 90:9581-9585.
102. Royo, J., Nas, N., Matton, D.P., Okamoto, S., Clarke, A.E., and Newbigin, E. 1996. A retroposon-like sequence linked to the S-locus of Nicotiana alata is expressed in styles in response to touch. Mol. Genet. 250:180-188.
103. Sohlberg, B., Lundberg, U., Hartl, F.U., and von Gabain, A. 1993. Functional interaction of heat shock protein Gro EL with an RNase E-like activity in Escherichia coli. Proc. Natl. Acad. Sci. 90:277-281.
104. Huynh, Q.K., Borgmeyer, J.R., Smith, C.E., Bell, L.D., and Shah, D.M. 1996. Isolation and characterization of a 30kDA protein with antifungal activity from leaves of Engelmannia pinnatifida. Biochem. J. 316:723-727.
105. Wantanabe, Y., Ogawa, T., Takahashi, H., Ishida, I., Takeuchi, Y., Yamamoto, M., and Okada, Y. 1995. Resistance against multiple plant viruses in plants mediated by a double stranded-RNA specific ribonuclease. FEBS Letters 372:165-168.
106. Youle, R.J., Wu, Y.N., Mikulski, S.M., Shogen, K., Hamilton, R.S., Newton, D., et al. 1994. RNase inhibition of human immunodeficiency virus infection of H9 cells. Proc. Natl. Acad. Sci. 91:6012-6016.
107. Wang, L.M., Zhou, A.M., Vasavada, S., Dong, B.H., Nie, H.Q., Church, J.M., et al. 1995. Elevated levels of 2′,5′-linked oligoadenylate-dependent ribonuclease L occur as an early event in colorectal tumorigenesis. Clin. Cancer Res. 1:1421-1428.
108. Hubbell, H.R., Kariko, K., Suhadolnik, R.J., and Brodsky, I. 1994. RNase L and increased endoribonuclease activities in the mononuciear cells of patients with chronic myelogenous leukemia. Anticancer Res. 14:341-346.
109. Suhadolnik, R.J., Reichenbach, N.L., Hitzges, P., Sobol, R.W., Peterson, D.L., Henry, B., et al. 1994 Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin. Infect. Disease Suppl 1:S96-104
110. Tomassini, M., Magrini, L., Bonini, S., Lambiase, A., and Bonini, S. 1994. Increased serum levels of eosinophil cationic protein and eosinophil-derived neurotoxin (protein X) in vernal keratoconjunctivitis. Ophthalmol. 101:1808-1811.
111. Morley, D.J., Hodes, J.E., Calland, J., and Hodes, M.E. 1983. Immunohisto-chemical demonstration of ribonuclease and amylase in normal and neoplastic parotid glands. Hum. Pathol. 14:969-973.
112. Karawya, E.M. and Alwabel, A.H.A. 1996. Elevated levels of ribonucleases in serum of patients with liver disease. Saudi Medical J. 17:42-46.
113. Barzilay, G., Walker, L.J., Robson, C.N., and Hickson, I.D. 1995. Site-directed mutagenesis of the human DNA repair enzyme HAP1: identification of residues important for AP endonuclease and RNase H activity. Nucl. Acids Res. 23:1544-1550.
114. Naskalski, J.W. 1989. Determination of ribonuclease activity in serum of patients with pancreatic necrosis. An attempt of extending the enzyme diagnosis of acute pancreatitis. Zeitschrift für medizinische Laboratoriums-diagnostik 30:425-430.
115. Allinquant, B., Musenger, C., and Schuller, E. 1984. Intrathecal origin of CSF ribonuclease. Differences between infectious processes of the nervous system and multiple sclerosis. Acta Neurologica Scandinavica 70:12-19.